Lancing Devices And Equipment Market Report 2026

Lancing Devices And Equipment Market Overview

• Lancing Devices And Equipment market size has reached to $3.25 billion in 2025 • Expected to grow to $4.98 billion in 2030 at a compound annual growth rate (CAGR) of 9.1% • Growth Driver: Rising Prevalence Of Diabetes Driving Market Growth Due To Increased Need For Blood Glucose Monitoring Solutions • Market Trend: Innovative Blood Sugar Monitoring Accu-Chek Pico By F. Hoffmann-La Roche Ag Simplifies Diabetes Care For Older Adults • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Lancing Devices And Equipment Market?

Lancing devices and equipment refer to medical tools used to obtain small blood samples, for glucose testing in diabetic patients. These devices consist of a lancet, a small needle or blade, and a mechanism that punctures the skin, usually on the fingertip, to draw blood. Lancing devices feature adjustable depth settings to control penetration and minimize discomfort. They are essential for routine blood glucose monitoring and other diagnostic tests requiring capillary blood samples. The main products of lancing devices and equipment are safety lancets and standard lancets. Safety lancets are sterile, single-use devices intended for capillary blood sampling. The lancing devices and equipment types are reusable and disposable that are available at various penetration depths such as 0.8mm-1mm, 1.1mm- 1.5mm, 1.6mm-2.0mm, and others. The end-users are hospitals and clinics, homecare and home diagnostics, diagnostic centres and medical institutions, research and academic laboratories, and others.

What Is The Lancing Devices And Equipment Market Growth Forecast?

The lancing devices and equipment market size is expected to see strong growth in the next few years. It will grow to $4.98 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing demand for home diagnostics solutions, rising focus on patient comfort and compliance, expansion of chronic disease monitoring programs, growing adoption of minimally invasive sampling devices, increasing investments in personal healthcare technologies. Major trends in the forecast period include increasing adoption of single-use safety lancets, rising demand for pain-minimized sampling devices, growing use of home-based glucose monitoring, expansion of adjustable depth lancing technologies, enhanced focus on infection control.

Global Lancing Devices And Equipment Market Segmentation

1) By Usage Mode: Reusable, Disposable 2) By Product: Safety Lancets, Standard Lancets 3) By Penetration Depth: 0.8mm-1mm, 1.1mm- 1.5mm, 1.6mm-2.0mm, Other Penetration Depths 4) By End User: Hospitals and Clinics, Homecare and Home Diagnostics, Diagnostic Centres and Medical Institutions, Research and Academic Laboratories, Other End User Subsegments: 1) By Reusable: Manual Reusable Lancets, Automated Reusable Lancets 2) By Disposable: Pre-filled Disposable Lancets, Single-use Lancets

What Is The Driver Of The Lancing Devices And Equipment Market?

The rising prevalence of diabetes is driving the growth of the lancing devices and equipment market going forward. Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels, requiring regular monitoring to manage the condition effectively and prevent complications such as neuropathy, cardiovascular disease, and kidney damage. The rising prevalence of diabetes is due to increasing obesity rates, which cause insulin resistance and metabolic dysfunction that lead to the development of the disease. The increasing prevalence of diabetes supports the lancing devices and equipment by boosting demand for safe, accurate, and easy-to-use blood sampling tools that enable frequent glucose testing at home or in clinical settings. For instance, in February 2025, according to The Guardian, a United Kingdom based news organization, a total of 12.2 million people were affected by diabetes or non-diabetic hyperglycaemia in the United Kingdom, including 4.6 million with diagnosed diabetes, 1.3 million with undiagnosed diabetes, and 6.3 million with non-diabetic hyperglycaemia, up from an estimated 12.1 million cases in 2023 to 2024. Therefore, the rising prevalence of diabetes is propelling the growth of the lancing devices and equipment industry.

Key Players In The Global Lancing Devices And Equipment Market

Major companies operating in the lancing devices and equipment market are Abbott laboratories, B. Braun Melsungen AG, Terumo Corporation, F. Hoffmann-La Roche AG, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Becton Dickinson and Company, Bayer AG, Medtronic plc, ARKRAY Inc., Sanofi S.A., Ypsomed Holding AG, Sarstedt AG & Co., Greiner Bio-One, HTL-STREFA S.A, Guangzhou Improve Medical Instruments Co. Ltd., UltiMed Inc., Allison Medical Inc., Artsana S.p.a., Perrigo Diabetes Care, MedExel Co. Ltd., Simple Diagnostics, Stat Medical Inc., Trividia Health, Eli Lilly and Company, Roche Diagnostics, Terumo Corporation, LifeScan, Dynarex Corporation, Dealmed Medical Supplies LLC, Advanced Diabetic Solutions, Medline Industries Inc., Owen Mumford, ARKRAY USA Inc., Nipro Diagnostics Inc., AgaMatrix Inc., Nova Biomedical, Prodigy Diabetes Care LLC, ACON Laboratories Inc.

Global Lancing Devices And Equipment Market Trends and Insights

Major companies operating in the lancing devices and equipment market are developing innovative products such as disposable lancing device to provide a more convenient and comfortable blood sugar monitoring experience. A disposable lancing device is a tiny, portable device that pricks the skin and collects a small blood sample for glucose testing. For instance, in August 2023, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, launched Accu-Chek Pico, a fully disposable lancing device that is designed to make blood sugar monitoring easier and more convenient for people with diabetes, especially older adults. It offers a number of benefits for people with diabetes, especially older adults. It is easy to use, gentle on the skin, provides consistent lancing depths, and is fully disposable. In addition, it is also compatible with a variety of Accu-Chek blood glucose meters. This makes it easy for people with diabetes.

What Are Latest Mergers And Acquisitions In The Lancing Devices And Equipment Market?

In October 2023, Novo Nordisk, a Denmark-based pharmaceutical company, acquired Biocorp for $164.5 million. This acquisition is intended to bolster Novo Nordisk's investments in drug delivery systems and medical devices, aligning with their focus on diabetes care solutions. The acquisition not only strengthens Novo Nordisk's position in the diabetes market but also enhances its capabilities in developing advanced lancing devices and drug delivery systems through innovative technology integration. Biocorp is a France-based company, specializes in developing blood glucose meters, lancing devices, insulin pumps.

Regional Outlook

North America was the largest region in the global lancing devices and equipment market in 2025. Western Europe was the second-largest region in the lancing devices and equipment market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

What Defines the Lancing Devices And Equipment Market?

The lancing devices and equipment market consist of sales of safety lancets and standard lancets, flake lancets And fixed depth lancet. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.